- Filed
- Feb 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 113.07M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.56B |
| Long Term Debt | Q1 2025 · Sep 30, 2024 | $2.56B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $743M |
| Short Term Debt | Q1 2025 · Sep 30, 2024 | $771M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $6M |
| Short Term Investments | Q1 2025 · Sep 30, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $471M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $471M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.39B |
| Stockholders Equity | Q1 2025 · Sep 30, 2024 | $3.5B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.48B |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $3.6B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.75B |
| Current Assets | Q1 2025 · Sep 30, 2024 | $3.88B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $10.94B |
| Total Assets | Q1 2025 · Sep 30, 2024 | $11.23B |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 115.2M sh |
| Stock Repurchased restated | Q1 2025 · Dec 31, 2023 | $120M |
| Dividends Paid | Q1 2025 · Dec 31, 2023 | $144M |
| Capex restated | Q1 2025 · Dec 31, 2023 | $68M |
| Operating Cash Flow restated | Q1 2025 · Dec 31, 2023 | $33M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $1.86 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $1.87 |
| Sga Expense restated | Q1 2025 · Dec 31, 2023 | $514M |
| Net Income restated | Q1 2025 · Dec 31, 2023 | $215M |
| Gross Profit restated | Q1 2025 · Dec 31, 2023 | $795M |
| Cost Of Revenue restated | Q1 2025 · Dec 31, 2023 | $1.26B |
| Revenue restated | Q1 2025 · Dec 31, 2023 | $2.05B |